On January 5, 2026, Beneficient finalized a capital transaction involving a limited partner interest valued at $3,022,728, resulting in the issuance of 302,273 shares of Series B-9 Preferred Stock, convertible into Class A Common Stock at a price starting at $7.1332 per share.